Clinical Trials Browser

Withdrawn × IRX 2 × Clear all

NCT03575234 2019-08-28

Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer

Phase 1 Withdrawn

Squamous Cell Carcinoma of Head and Neck